Tagged with Access

access The president of Turkey’s social security institution, the SGK, discusses the evolution of healthcare spending over the past three years, and the underpinning principles guiding their drug reimbursement policy decisions. Since 2012, medical expenses have been increasing; can you please analyze the situation? Since 2006, the ‘Sosyal Güvenlik Kurumu’ (SGK),…

regulator Flor de María Philipps, Superintendent of Susalud, discusses her role in ensuring that healthcare providers throughout Peru are performing to the best of their ability.   What is the main mission of Susalud? Our mission is to protect health-related rights of Peruvians. We are a public organization under the Ministry…

Bayer Worldwide, Bayer is experiencing a strong business momentum thanks to an avalanche of innovation. The general manager of Bayer HealthCare Pharmaceuticals in Mexico shares his perspectives about the recent developments of the market, how the company is partnering up with authorities to promote access and how the company is preparing…

generics After Brazil, Torrent is looking to strengthen its foothold in the Mexican market. The general manager of the local affiliate explains the opportunities Latin America offers to Indian companies, how – despite an apparent slackening performance – the Mexican pharmaceutical market is growing and how niche is the name of…

Pfizer The country manager of Pfizer Morocco talks about the likelihood of Morocco becoming an African hub and why Pfizer is at the perfect size to play a key part in such a process, as well as how the country’s price decree hurt the multinational corporations.   Having been elected head of MIS…

generics At Valeant each region has a unique mix of prescription brands, branded generics and OTC products. The general manager for Mexico, Central America, the Caribbean and the Andean region discusses the company’s objectives for Spanish speaking Latin America and how it plans to leverage the recently acquired Bausch+Lomb business to…

PwC The partner and leader of the healthcare practice for Mexico and Hispanic America shares his vision about how Mexico’s healthcare sector is converging to look at innovative ways to understand how health impacts on the economic growth of the country.     Back in 2012 you told us that the…

access Healthcare should not be seen as an expenditure, but rather as an investment. Mexico’s former minister of health and current dean at the Harvard T.H. Chan School of Public Health discusses how Mexico is moving towards effective universal coverage, the challenges the system is facing and the issues that remain.…

clinical research Clinical research and access are the name of the game. The Executive Director of the association bringing together the most important research-based pharmaceutical companies discusses how the association has stepped up to partner up with the government and stakeholders to fight for the same objective and create a better health…

Novo Nordisk The global COO of the multinational at the forefront of the fight against diabetes explains why the Algerian market is so strategically important and how the ‘made in Algeria’ brand would have real potential at the regional level if only the government would remove impediments to export. As COO of Novo…

sales UCB has transformed into a specialty care pharma which focuses on bringing solutions to patients suffering from severe chronic diseases. The vice president and region head for Americas discusses how the company re-entered key markets in the Latin American space to drive future growth, how the company’s three flagships products…

generics  Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth in the future.   You are currently the Vice President of CAPGEN; could you please tell us a bit about…